Post-market clinical follow-up is where the clinical evaluation of a device is kept honest. Under the MDR it is a continuous process, not a one-off study, and notified bodies expect to see a plan that answers specific questions, not a blank template.
Where PMCF sits
PMCF is the clinical part of the post-market surveillance system. The PMCF plan forms part of the PMS plan, and its results feed a PMCF evaluation report that in turn updates the clinical evaluation. The Medical Device Coordination Group has published templates for both: MDCG 2020-7 for the plan and MDCG 2020-8 for the evaluation report.
What a credible plan contains
The MDCG plan template asks, for each activity, for the source of the need (clinical evaluation, risk management or PMS), the aim, the method, the sample size, the endpoints, any comparator, the sources of bias and the limitations, with a justified timeline. Methods fall into two groups:
- General methods, such as literature screening, review of case reports for misuse or off-label use, structured surveys, and analysis of routine feedback.
- Specific methods, such as a device registry with a predefined dataset, a PMCF study, follow-up of patients from a pre-market investigation, or a planned real-world evidence analysis.
The right mix depends on the device and on the gaps left by the clinical evaluation. A retrospective survey with no statistical rationale is unlikely to convince a reviewer.
When PMCF is said to be unnecessary
If you conclude that no PMCF activity is needed, that conclusion still needs a device-specific justification which a notified body can assess. A generic statement is rarely enough.
Practical tips
- Start from the open questions in the clinical evaluation report and risk file, not from the template.
- Keep activity numbers stable between the plan and the evaluation report so the link is traceable.
- Schedule the first evaluation report realistically and link its findings back into the clinical evaluation and risk management.
How PQRA helps
PQRA supports manufacturers with PMCF planning, the drafting of plans and evaluation reports against the MDCG templates, and the integration of PMCF output into clinical evaluation, risk management and PMS documentation.
Reviewing a PMCF plan before your next notified body assessment? Contact PQRA for a practical discussion.


No responses yet